Leo F Verdonck - JoVE Visualize

Showing results (61-70 of 101) with videos related to

Pageof 11

Sort By:

Blood|October 24, 2002

High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patientsSahar Barjesteh van Waalwijk van Doorn-Khosrovani, Claudia Erpelinck, Wim L J van Putten, et al.

Nederlands Tijdschrift Voor Geneeskunde|October 28, 2010

[Autologous stem cell transplantation in haematological disorders,1980-2002]Mariëlle M J Beckers, Leo F Verdonck, Jan J Cornelissen, et al.

Blood|November 8, 2008

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparisonJan J Cornelissen, Bronno van der Holt, Gregor E G Verhoef, et al.

Haematologica|December 18, 2009

Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemiaWendy Deenik, Jeroen J W M Janssen, Bronno van der Holt, et al.

Blood|January 4, 2008

Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemiaWendy Deenik, Bronno van der Holt, Gregor E G Verhoef, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012

Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative GroupStefan Gröschel, Richard F Schlenk, Jan Engelmann, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 7, 2018

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free SurvivalAmin Alousi, Tao Wang, Michael T Hemmer, et al.

Haematologica|August 8, 2024

Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III studyDietger Niederwieser, Dirk Hasenclever, Wolfgang E Berdel, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2014

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for LeukemiaMichael Boyiadzis, Mukta Arora, John P Klein, et al.

Blood|December 9, 2008

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantationOlle Ringdén, Steven Z Pavletic, Claudio Anasetti, et al.

Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:

Pageof 11

Blood|October 24, 2002

High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patientsSahar Barjesteh van Waalwijk van Doorn-Khosrovani, Claudia Erpelinck, Wim L J van Putten, et al.

Nederlands Tijdschrift Voor Geneeskunde|October 28, 2010

[Autologous stem cell transplantation in haematological disorders,1980-2002]Mariëlle M J Beckers, Leo F Verdonck, Jan J Cornelissen, et al.

Blood|November 8, 2008

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparisonJan J Cornelissen, Bronno van der Holt, Gregor E G Verhoef, et al.

Haematologica|December 18, 2009

Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemiaWendy Deenik, Jeroen J W M Janssen, Bronno van der Holt, et al.

Blood|January 4, 2008

Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemiaWendy Deenik, Bronno van der Holt, Gregor E G Verhoef, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012

Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative GroupStefan Gröschel, Richard F Schlenk, Jan Engelmann, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 7, 2018

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free SurvivalAmin Alousi, Tao Wang, Michael T Hemmer, et al.

Haematologica|August 8, 2024

Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III studyDietger Niederwieser, Dirk Hasenclever, Wolfgang E Berdel, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2014

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for LeukemiaMichael Boyiadzis, Mukta Arora, John P Klein, et al.

Blood|December 9, 2008

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantationOlle Ringdén, Steven Z Pavletic, Claudio Anasetti, et al.

Pageof 11